Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo
International Journal of Molecular Sciences · 16.04.2026 · 27 (8) · 3554
DOI: 10.3390/ijms27083554 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.04.2026. Verfasst von Zhiming Ling und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Beijing University of Chinese Medicine, Beijing 102488, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Interleukin-15, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chimeric antigen receptor–natural killer (CAR-NK) cell therapy is a promising immunotherapy for hematological malignancies. While engineered interleukin15 (IL15) variants like membrane-bound IL15 (mbIL15) and the IL15/IL15Rα heterodimer (RLI) can enhance NK cell activity, their relative efficacy and safety as armor for CAR-NK cells remain unclear. This study systematically evaluated primary human CAR-NK cells co-expressing an anti-CD19 CAR (19ζ) with soluble IL15, mbIL15, or RLI. We found that 19ζ-RLI CAR-NK cells exhibited superior IL15 secretion, proliferation, cytotoxicity, and migration in vitro, and effectively controlled tumors in vivo. However, all IL15-armored constructs, particularly 19ζ-RLI, induced lethal toxicity in mice, characterized by CAR-NK hyperproliferation and elevated systemic IL15. Transcriptomic analysis revealed that this toxicity correlated with a hyperactive molecular state driven by persistent IL15 signaling. In conclusion, this study suggests that constitutive IL15 armoring can be a potent but risky strategy for enhancing CAR-NK cells, with RLI being the most potent yet toxic exemplar of this general principle. Our findings highlight the necessity of incorporating safety-optimized strategies, such as inducible cytokine expression, into the design of cytokine-armored CAR-NK therapies for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science, Beijing University of Chinese Medicine, Beijing 102488, China.
Zitieren
APA
Ling, Z., Wang, Y., Wu, G., Lin, W., Lu, T., Yu, G., & Wang, J. (2026). Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo. International Journal of Molecular Sciences, 27(8), 3554. https://doi.org/10.3390/ijms27083554
Vancouver
Ling Z, Wang Y, Wu G, Lin W, Lu T, Yu G, et al. Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo. International Journal of Molecular Sciences. 2026;27(8):3554. doi:10.3390/ijms27083554
BibTeX
@article{Ling2026,
author = {Ling, Zhiming and Wang, Yi and Wu, Geping and Lin, Wei and Lu, Tao and Yu, Guohua and Wang, Jianxun},
title = {Constitutive RLI Armoring Enhances CAR-NK Cell Effector Functions but Causes Lethal Toxicity In Vivo},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {8},
pages = {3554},
doi = {10.3390/ijms27083554}
}
EUVIMED